| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | 2 | 1 | — | 2 | — | — |
| Sell | — | 1 | — | — | — | — | — | 1 | — | 1 | — | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 1.77 |
—
—
—
|
| 2025 | 1.68 |
—
—
—
—
|
| 2024 | 1.60 |
—
—
—
—
|
| 2023 | 1.52 |
—
—
—
—
|
| 2022 | 1.44 |
—
—
—
—
|
| 2021 | 1.36 |
—
—
—
—
|
| 2020 | 1.28 |
—
—
—
—
|
| 2019 | 1.20 |
—
—
—
—
|
| 2018 | 1.12 |
—
—
—
—
|
| 2017 | 1.04 |
—
—
—
—
—
|
| 2016 | 0.81 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 9.72 | 11.11 | 20.69 | 104.10 |
| Receivables | 76.74 | 81.69 | 72.90 | 82.86 |
| Inventory | — | — | — | — |
| Other | 100.82 | 87.61 | 85.37 | 97.80 |
| 198.39 | 190.71 | 190.59 | 296.40 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 46.12 | 56.26 | 75.43 | 70.44 |
| ST’ Debt | 220.48 | 122.77 | 110.34 | 10.01 |
| Other | 23.85 | 24.36 | 20.94 | 25.85 |
| 342.97 | 261.17 | 273.38 | 177.84 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 183.29 | 210.47 | — | — |
—
|
| ’25 | 167.60 | 198.26 | 240.55 | 194.19 |
800.59
|
| ’24 | 149.38 | 176.17 | 225.06 | 197.82 |
748.44
|
| ’23 | 137.30 | 156.89 | 204.84 | 171.34 |
670.36
|
| ’22 | 124.30 | 149.04 | 175.98 | 171.37 |
620.70
|
| ’21 | 114.79 | 152.24 | 166.92 | 139.74 |
573.69
|
| ’20 | 115.75 | 147.21 | 165.86 | 135.70 |
564.53
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 43.71 | 60.74 | — | — |
—
|
| ’25 | 43.18 | 60.84 | 77.27 | 63.52 |
244.80
|
| ’24 | 51.22 | 49.32 | 53.53 | 41.46 |
195.53
|
| ’23 | 50.61 | 46.76 | 61.94 | 31.53 |
190.83
|
| ’22 | 45.29 | 38.30 | 45.75 | 36.85 |
166.20
|
| ’21 | 33.38 | 33.72 | 33.16 | 29.79 |
130.04
|
| ’20 | 7.93 | 24.41 | 38.28 | 33.44 |
104.05
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (48.80) | (61.20) | — | — |
—
|
| ’25 | (41.16) | (71.22) | (75.95) | (86.62) |
(274.95)
|
| ’24 | (22.29) | (47.32) | (47.35) | (64.74) |
(181.71)
|
| ’23 | (4.48) | (23.19) | (22.57) | (71.80) |
(122.04)
|
| ’22 | (3.21) | (27.90) | (17.51) | (26.55) |
(75.18)
|
| ’21 | (17.95) | (19.37) | (41.18) | (25.08) |
(103.59)
|
| ’20 | (34.01) | (12.77) | (21.54) | (39.32) |
(107.65)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.49 | 0.62 | — | — |
—
|
| ’25 | 0.49 | 0.71 | 1.27 | 0.45 |
2.92
|
| ’24 | 0.36 | 0.64 | 1.17 | 0.68 |
2.87
|
| ’23 | 0.37 | 0.58 | 1.13 | 0.59 |
2.68
|
| ’22 | 0.12 | 0.38 | 0.82 | 1.09 |
2.43
|
| ’21 | 0.09 | 0.69 | 0.64 | 0.60 |
2.03
|
| ’20 | 0.08 | 0.69 | 0.91 | 0.46 |
2.14
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 55.74 | 56.96 | 48.78 | 43.75 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 83.88 | 83.66 | 66.22 | 57.17 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 757 | 808 | 822 | 837 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.82 | 0.83 | 0.91 | 0.96 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 620.70 | 670.36 | 748.44 | 800.59 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | 62.50% | 61.78% | 60.98% | 61.13% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 82.32 | 90.94 | 102.94 | 114.93 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 13.26% | 13.57% | 13.75% | 14.36% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 73.83 | 84.99 | 93.97 | 102.58 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 106.44 | 108.14 | 115.05 | 120.49 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 20.48 | 21.23 | 22.89 | 22.87 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 2.44 | 2.69 | 2.87 | 2.93 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.48 | 6.04 | 5.98 | 6.99 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (7.96) | (9.91) | (11.54) | (14.85) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.48) | (3.87) | (5.56) | (7.86) | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 36.66 | 39.06 | 41.80 | 44.02 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 30.31 | 31.58 | 32.70 | 35.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 33.84 | 24.50 | 17.21 | 16.78 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.01 | 3.09 | 2.15 | 2.14 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.24 | 1.68 | 1.18 | 1.11 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.66 | 5.68 | 4.58 | 4.59 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (55.01) | (31.22) | (18.87) | (13.35) | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 166.20 | 190.83 | 195.53 | 244.80 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (241.37) | (312.87) | (377.24) | (519.75) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (75.18) | (122.04) | (181.71) | (274.95) | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (109.94) | (144.58) | (70.46) | (82.78) | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,655.90 | 1,747.17 | 1,829.68 | 1,977.16 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,643.56 | 1,737.45 | 1,818.56 | 1,956.47 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,110.87 | 1,233.40 | 1,366.97 | 1,540.77 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.04% | 2.10% | 2.09% | 2.09% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.97% | 3.14% | 3.35% | 3.17% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.88% | 7.25% | 7.23% | 7.06% | — | — | — |
ROE
|
H2O America (HTO) has demonstrated impressive resilience in the water infrastructure sector, growing revenue from $340 million in 2016 to $748 million in 2024 at a 10.5% CAGR, fueled by U.S. infrastructure bills and demand for purification technologies despite supply chain woes and regulatory pressures. In 2024, sales surged 12% year-over-year, with revenue per employee jumping 10% to $911,000, signaling strong productivity gains even as headcount rose modestly. Projections show sustained expansion to $908 million by 2027 (7% CAGR), supported by desalination projects and ESG trends, though moderating from peak growth.
Profitability is stabilizing with gross margins at 61%, EBT margins up to 13.8%, and net income climbing 11% to $94 million (EPS $2.87, +7%), alongside ROE at a solid 7.2%. Yet, aggressive capex of $337 million drove free cash flow deeper into negative territory at -$141 million, ballooning debt to $1.83 billion—manageable but a red flag amid rising rates. Balance sheet strength persists with book value per share up 7% to $41.80, but persistent FCF drag has capped stock gains, with shares trading in a $49-$66 range versus 2022 highs of $84.
At a discounted forward P/E of 18.5x, P/S 2.2x, and P/B 1.2x—well below historical averages—HTO appears undervalued relative to peers and growth prospects, with analyst targets implying 11% upside and potential FCF inflection by 2028. No insider buys amid earnings gains add a cautious note, but correlations between revenue momentum and ROE stability suggest overweight potential for patient investors betting on infrastructure tailwinds and capex moderation.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.